Study reveals shorter scans for prostate cancer could improve diagnosis
The most common form of cancer in men is responsible for 12,000 deaths every year in the UK
Read More
Tag: John Block Charitable Foundation
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
- Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
- HUTCHMED begins phase 3 stage of pancreatic cancer trial
- Zenas reports strong phase 3 results for obexelimab in IgG4-related disease
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
